Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Expands By 30.0%

Lexaria Bioscience Corp. (NASDAQ:LEXXW) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling 1,906 shares, a growth of 30.0% from the December 15th total of 1,466 shares. Based on an average daily volume of 40,357 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily volume of 40,357 shares, the days-to-cover ratio is presently 0.0 days.

Lexaria Bioscience Trading Down 77.4%

NASDAQ:LEXXW traded down $0.00 during midday trading on Friday, reaching $0.00. 283,190 shares of the company traded hands, compared to its average volume of 55,749. The company has a fifty day moving average price of $0.02 and a 200 day moving average price of $0.07. Lexaria Bioscience has a twelve month low of $0.00 and a twelve month high of $0.80.

About Lexaria Bioscience

Lexaria Bioscience Corp. is a pharmaceutical company specializing in the development of novel drug delivery platforms for orally administered, lipid-soluble molecules. The company’s core technology, DehydraTECH®, is designed to enhance the absorption, onset and bioavailability of compounds such as cannabinoids, nicotine and certain pharmaceutical actives. By embedding these compounds into food and beverage products or nutraceuticals, Lexaria aims to offer a more efficient alternative to traditional delivery methods.

Established in 2012 and headquartered in Kelowna, British Columbia, Lexaria has conducted preclinical and clinical studies to validate its DehydraTECH® platform.